Buy/Sell: Wall Street’s top 10 stock calls this week

What has Wall Street been buzzing about this week? Here are the top 5 Buy calls and the top 5 Sell calls made by Wall Street’s best analysts during the week of January 12-16. 

Find all top-rated stocks by the best-rated analysts on TipRanks.

Top 5 Buy Calls:

1. Netflix initiated with a Buy at HSBC

HSBC initiated coverage of Netflix (NFLX) with a Buy rating and $107 price target. The firm says Netflix trades 33% below its summer 2025 peak share levels despite expected gains from deepening monetization, improving profitability, and a sizable international opportunity offsetting a maturing domestic market. Netflix’s turn to acquisitions reflects the challenges of a maturing video streaming industry, the analyst tells investors in a research note. HSBC believes Netflix is the “undisputed global streaming leader.”

2. Nvidia initiated with an Outperform at RBC Capital

RBC Capital initiated coverage of Nvidia (NVDA) with an Outperform rating and $240 price target. The firm sees “limited threat” to Nvidia’s full-stack AI dominance, despite the recent progress by ASICs and AMD (AMD), the analyst tells investors. The firm expects any hyperscaler capex spending slowdown to be gradual and believes that valuation is already discounting a potential slowdown to an extent, adding that it has higher conviction in Nvidia’s order book than that of peers.

3. DraftKings upgraded to Overweight at Wells Fargo

Wells Fargo upgraded DraftKings (DKNG) to Overweight from Equal Weight with a price target of $49, up from $31, as part of broader research previewing 2026 in Digital Gaming. The firm remains upbeat on long-term growth dynamics in Digital and anticipates robust 2026 profit growth, though it also believes that DraftKings offers better near-term upside with expectations of a “strong” Q4 for the company, Wells tells investors.

4. Uber initiated with an Outperform at BNP Paribas

BNP Paribas initiated coverage of Uber (UBER) with an Outperform rating and $108 price target. Despite fears of autonomous vehicles disintermediating the business in the long-term, the firm views Uber as “a mobility and delivery winner,” even in an AV future.

5. Airbnb upgraded to Buy at B. Riley

B. Riley upgraded Airbnb (ABNB) to Buy from Neutral with a price target of $170, up from $140. The firm cites the stock’s attractive valuation and the company’s prospects for sustained “healthy” growth and margin expansion. B. Riley sees room for share upside in a stable demand environment for travel. Airbnb is positioned to benefit from secular growth in short-term rentals and its international expansion but should also get an uplift from the broader rollout of “reserve now pay later” and the addition of hotel inventory in supply-constrained markets, B. Riley tells investors in a research note.

Top 5 Sell Calls:

1. Rivian downgraded to Sell at UBS

UBS downgraded Rivian (RIVN) to Sell from Neutral with a price target of $15, up from $13. The firm cites “elevated expectations” for the downgrade. Rivian shares are “prone to sentiment swings” and the stock is up 15% since the company’s autonomy and AI day on December 11, UBS tells investors in a research note. However, the firm believes most of Rivian’s AI related news is out. It also thinks expectations may be too high for the R2 launch.

Rivian downgraded to Underperform at Wolfe Research

Wolfe Research downgraded Rivian to Underperform from Peer Perform with a $16 price target. The risk/reward appears unfavorable at current levels, as Rivian’s fundamentals have weakened despite recent share gains driven by autonomy enthusiasm, with 2026 Street expectations viewed as overly optimistic, the firm tells investors in a research note. Higher EBITDA losses, increased free cash flow burn, potential R2 demand risk, and limited near-term autonomy catalysts point to downside risk, Wolfe says.

2. Snap initiated with an Underperform at BNP Paribas

BNP Paribas initiated coverage of Snap (SNAP) with an Underperform rating and $8 price target. Declines in the U.S. have persisted alongside “anemic” growth in the EU, says the firm, which is looking for evidence that investments are improving monetization.

3. GE HealthCare downgraded to Sell at UBS

UBS downgraded GE HealthCare (GEHC) to Sell from Neutral with a price target of $77, up from $73. The firm says the “enthusiasm” around Flyrcado and photon-counting computed tomography, which has driven GE HealthCare shares to near all-time highs, is understandable. However, UBS now sees risks, saying the company’s “best-case execution scenarios” are priced into the stock. The positives are well known, but the risks less so, the firm tells investors in a research note.

4. HP Inc. downgraded to Underweight at Barclays

Barclays downgraded HP Inc. (HPQ) to Underweight from Equal Weight with a price target of $18, down from $24. While the shares are “inexpensive,” secular challenges across both computers and printing, combined with a lack of catalysts, will keep HP pressured in 2026, the firm tells investors in a research note. Additionally, Barclays expects the current memory cycle to pressure the company’s PC business with further downside potential in the year.

Goldman Sachs assumes HP Inc. at Sell 

Goldman Sachs downgraded HP Inc. to Sell from Hold with a $21 price target following a transfer in analyst coverage. After a stronger than expected FY25 and given potential demand impacts from higher pricing, consensus expectations for Personal Systems growth in FY26 may be too high, the firm tells investors.

5. Albertsons downgraded to Underweight at Morgan Stanley

Morgan Stanley downgraded Albertsons (ACI) to Underweight from Equal Weight with a price target of $14, down from $20. The firm cites the company’s market share loss, pharmacy pressure, and disinflation for the downgrade. The “grocery wars” are intensifying with price investments, e-commerce partnerships, and promotional activity increasing pressure, Morgan Stanley tells investors.